This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC London

Legal Notice

CLINICAL PHARMACY CONGRESS IS SPONSORED BY THE PHARMACEUTICAL AND MED TECH INDUSTRIES VIA GRANTS, SPONSORSHIP, AND EXHIBITION PACKAGES. PHARMACEUTICAL COMPANIES HAVE SOLELY PROVIDED SPONSORSHIP THROUGH THE PURCHASE OF EXHIBITION SPACE AND/OR SPONSORED SPEAKER SESSIONS WITH NO FURTHER INPUT INTO THE ARRANGEMENTS OR AGENDA OF THE MEETING. SESSIONS DELIVERED WITH INPUT FROM OUR SPONSORS WILL ALWAYS BE MARKED ON THE PROGRAMME. A FULL LIST OF CONFIRMED SPONSORS FOR CLINICAL PHARMACY CONGRESS LONDON IS AVAILABLE HERE.  

CPC 2026 Content Programme

Subpage Hero

.

Loading

Benzodiazepine deprescribing: why, when, and how?

09 May 2026
Clinical Theatre 2
Benzodiazepine deprescribing: why, when, and how?

This is a panel discussion about benzodiazepine deprescribing - practical and evidence based approach.

  • How to deprescribe benzodiazepines - identifying which patients, which medication timing and practical strategies
Speakers
Anne Connolly, Associate Chief Pharmacist - North London NHS Foundation Trust
Roz Gittins, Chief Pharmacy Officer & Deputy Registrar - General Pharmaceutical Council
Amira Guirguis, Senior Lecturer, Biomedical Sciences - Swansea University
Adam Winstock, Consultant Psychiatrist & Addiction Medicine Specialist - UCL & Staying Safer

Newsletter Sign Up